J Hamada Selected Research

Proteins (Proteins, Gene)

1/2003	The neuroprotective effect of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, in transient forebrain ischemia.
4/2001	Interaction of MCC2, a novel homologue of MCC tumor suppressor, with PDZ-domain Protein AIE-75.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Hamada Research Topics

Disease

7	Neoplasms (Cancer) 07/2013 - 01/2000
4	Ischemia 01/2003 - 09/2001
3	Neoplasm Metastasis (Metastasis) 07/2013 - 01/2000
2	Brain Ischemia (Cerebral Ischemia) 01/2003 - 01/2003
2	Aneurysm (Aneurysms) 12/2001 - 06/2000
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2003
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2001
1	Hypoxia (Hypoxemia) 10/2001
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2001
1	Hypotension (Low Blood Pressure) 09/2001
1	Colonic Neoplasms (Colon Cancer) 04/2001
1	Autoimmune enteropathy 04/2001
1	Periarthritis 04/2001
1	Hemorrhage 03/2001
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2001
1	Retinal Perforations 01/2001
1	Carcinoma (Carcinomatosis) 09/2000
1	Ruptured Aneurysm 09/2000
1	Squamous Cell Carcinoma of Head and Neck 09/2000
1	Intracranial Vasospasm 09/2000
1	Carcinogenesis 06/2000
1	Hepatitis 02/2000
1	Hepatocellular Carcinoma (Hepatoma) 02/2000
1	Breast Neoplasms (Breast Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2003 - 01/2001
2	Proteins (Proteins, Gene)FDA Link 01/2003 - 04/2001
2	Neuroprotective AgentsIBA 01/2003 - 11/2001
2	DNA (Deoxyribonucleic Acid)IBA 02/2001 - 01/2000
1	MicroRNAs (MicroRNA)IBA 07/2013
1	IndazolesIBA 01/2003
1	Caspase 12IBA 01/2003
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2003
1	3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA 01/2003
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2003
1	salicylhydroxamic acid (SHAM)IBA 01/2003
1	Vanadates (Orthovanadate)IBA 11/2001
1	SodiumIBA 11/2001
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2001
1	Transcription Factors (Transcription Factor)IBA 10/2001
1	Oxygen (Dioxygen)IBA 10/2001
1	Codon (Codons)IBA 10/2001
1	NitritesIBA 09/2001
1	AutoantigensIBA 04/2001
1	AntigensIBA 04/2001
1	tricalcium phosphateIBA 04/2001
1	Durapatite (Hydroxylapatite)IBA 04/2001
1	Phosphates (Orthophosphate)IBA 04/2001
1	CalciumIBA 04/2001
1	Oxidized CelluloseIBA 03/2001
1	Epidermal Growth Factor (EGF)IBA 02/2001
1	PeroxidesIBA 02/2001
1	8-Hydroxy-2'-DeoxyguanosineIBA 02/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2001
1	Endothelin-1 (Endothelin 1)IBA 01/2001
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2000
1	matrigelIBA 09/2000
1	diisopropyl 1,3-dithiol-2-ylidenemalonate (malotilate)IBA 09/2000
1	Hematoxylin (Haematoxylon)IBA 06/2000
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2000
1	trichrome stainIBA 06/2000
1	Biological ProductsIBA 06/2000
1	CopperIBA 02/2000
1	EnzymesIBA 01/2000
1	Estrogen ReceptorsIBA 01/2000
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2000
1	Annexin A2 (Annexin II)IBA 01/2000
1	OsteopontinIBA 01/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2000

Therapy/Procedure

1	Ligation 12/2001
1	Length of Stay 11/2001
1	Drug Therapy (Chemotherapy) 01/2000